Skip to main content

Table 1 Clinicopathologic characteristics

From: Risk factors for lymph node metastasis and surgical methods in patients with early-stage peripheral lung adenocarcinoma presenting as ground glass opacity

Variable

Total

pN0

pN1 + N2

X2

P value

All patients

327

301

26

  

Age (years)

   

2.264

0.322

  ≥ 60

172

162

10

  

  < 60

155

139

16

  

Gender

   

5.663

0.017

 Male

121

117

4

  

 Female

206

184

22

  

Smoking history

   

1.593

0.207

 Present

139

131

8

  

 Absent

188

170

18

  

Tumor size (cm)

   

29.986

0.000

  < 1.0

79

79

0

  

 1.1–2.0

140

135

5

  

 2.1–3.0

108

87

21

  

Consolidation tumor ratio(C/T)

   

14.676

0.001

 0

43

43

0

  

 0 to ≤0.5

50

50

0

  

 0.5to<1

120

111

9

  

 1

114

97

17

  

CEA level (ng/mL)

   

5.246

0.022

  ≤ 5

268

251

17

  

 >5

59

50

9

  

Tumor location

   

0.569

0.966

 Right upper lobe

102

95

7

  

 Right middle lobe

31

28

3

  

 Right lower lobe

53

49

4

  

 Left upper lobe

79

73

6

  

 Left lower lobe

62

56

6

  

Operations type

   

5.560

0.062

 Wedge

29

29

0

  

 Segmentectomy

43

42

1

  

 Lobectomy

255

230

25

  

Pathologic type

   

10.407

0.004

 AIS

31

31

0

  

 MIA

52

52

0

  

 IA

244

218

26

  

Lymphovascular invasion

   

53.189

0.000

 Present

51

34

17

  

 Absent

276

267

9

  

Pleural invasion

   

44.469

0.000

 Present

46

31

15

  

 Absent

281

270

11

  
  1. PGGO pure ground-glass opacity, AIS adenocarcinoma in situ, MIA minimally invasive adenocarcinoma, IA invasive adenocarcinoma.